-
Ferring and CDI sign agreement granting Ferring exclusive marketing rights to VSL#3® in Europe and Canada
inFerring Pharmaceuticals and CD Investments (CDI) announced today that they have signed an agreement granting Ferring exclusive European marketing…
-
Waking up to go to the toilet is the number one cause of a poor night’s sleep, say experts on World Sleep Day
inOn World Sleep Day sleep experts encourage people to understand the value of healthy and solid sleep…
-
Ferring collaborates with ICF on development of a potential new treatment for anal fissures with a focus on improving quality of care for IBD patients
inFerring Pharmaceuticals and Brazil-based Instituto de Ciências Farmacêuticas (ICF) today announced a research…
-
Ferring acquires ex-U.S. assets and rights for Vitaros® (alprostadil cream), Apricus’ on-demand topical cream for erectile dysfunction
inFerring Pharmaceuticals today announced an agreement with Apricus Biosciences, Inc. (Nasdaq:APRI), granting Ferring global…
-
Ferring Announces Recipients of Innovation Grants Program 2016-2017
inFerring today announced the recipients of the 2016-2017 Ferring Innovation Grants program, an annual initiative of the Ferring Research Institute…
-
Ferring and Foresee Pharmaceuticals Enter into Exclusive Development and Option Agreement
inFerring Pharmaceuticals and Foresee Pharmaceuticals Co., Ltd. (6576.TWO), announced today that the companies have entered into an exclusive…
-
Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement to Develop an Oral Formulation of a Peptide-based Injectable Therapeutic
inFerring Pharmaceuticals and Enteris BioPharma, Inc. announced today that the companies have entered…
-
Ferring partners with Intralytix to develop bacteriophage treatments for conditions associated with the microbiome and drug-resistant bacteria
inFerring Pharmaceuticals is partnering with Intralytix, Inc to develop and commercialise bacteriophage-based treatments…
-
Ferring and IMAB sign licensing agreement granting IMAB exclusive rights in Asia to olamkicept for the treatment of autoimmune disease
inFerring Pharmaceuticals and IMAB today announced that they have signed a licensing agreement which grants IMAB exclusive rights…
-
Ferring receives EU approval for REKOVELLE® (follitropin delta)
inFerring Pharmaceuticals announced today that the European Commission (EC) has granted marketing authorisation for REKOVELLE®…
Author archive for pulse
Articles by: pulse